N-Deschlorobenzoyl indomethacin (Compound 18), the primary metabolite of indomethacin ( HY-14397 ), lacks the N-p-chlorobenzoyl group in its structure. Consequently, N-Deschlorobenzoyl indomethacin loses inhibitory activity against AKR1C2 and AKR1C3 ( AKR1C2 IC 50 =100 μM, AKR1C3 IC 50 >100 μM), exhibiting no selectivity.
Products | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Others | Products > Signaling Pathways > Drug Metabolite
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.